Remdesivir Recruiting Phase 4 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

Indications	Status	Purpose	Phase
DBCOND0129755 (Coronavirus Disease 2019 (COVID‑19))	Recruiting	Treatment	4

clinicaltrials.gov Identifier	Title	Drugs
NCT04978259	SOLIDARITY Finland Long-COVID (Remdesivir Long-term Follow-up Study of COVID Patients)	Peracetic acid (DB14556) Remdesivir (DB14761)
NCT04738045	Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients	Lopinavir (DB01601) Remdesivir (DB14761) Ritonavir (DB00503)